Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Robert J. Parker is active.

Publication


Featured researches published by Robert J. Parker.


Cancer Investigation | 1985

Lymphatic Delivery of Monoclonal Antibodies: Potential for Detection and Treatment of Lymph Node Metastases

John N. Weinstein; Robert J. Parker; Oscar D. Holton; Andrew M. Keenan; David G. Covell; Christopher D.V. Black; Susan M. Sieber

AbstractTwo roads diverged in a wood, and I—I took the one less traveled by, And that has made all the difference.


PLOS Pathogens | 2017

Innate activation of human primary epithelial cells broadens the host response to Mycobacterium tuberculosis in the airways

Ann-Kathrin Reuschl; Michael R. Edwards; Robert J. Parker; David W. Connell; Long Hoang; Alice Halliday; Hannah Jarvis; Nazneen Siddiqui; Corrina Wright; Samuel Bremang; Sandra M. Newton; Peter Beverley; Robin J. Shattock; Onn Min Kon; Ajit Lalvani

Early events in the human airways determining whether exposure to Mycobacterium tuberculosis (Mtb) results in acquisition of infection are poorly understood. Epithelial cells are the dominant cell type in the lungs, but little is known about their role in tuberculosis. We hypothesised that human primary airway epithelial cells are part of the first line of defense against Mtb-infection and contribute to the protective host response in the human respiratory tract. We modelled these early airway-interactions with human primary bronchial epithelial cells (PBECs) and alveolar macrophages. By combining in vitro infection and transwell co-culture models with a global transcriptomic approach, we identified PBECs to be inert to direct Mtb-infection, yet to be potent responders within an Mtb-activated immune network, mediated by IL1β and type I interferon (IFN). Activation of PBECs by Mtb-infected alveolar macrophages and monocytes increased expression of known and novel antimycobacterial peptides, defensins and S100-family members and epithelial-myeloid interactions further shaped the immunological environment during Mtb-infection by promoting neutrophil influx. This is the first in depth analysis of the primary epithelial response to infection and offers new insights into their emerging role in tuberculosis through complementing and amplifying responses to Mtb.


Biochemical Journal | 2017

The helicase, DDX3X, interacts with poly(A)-binding protein 1 (PABP1) and caprin-1 at the leading edge of migrating fibroblasts and is required for efficient cell spreading

Alice Copsey; Simon Cooper; Robert J. Parker; Ella Lineham; Cuzack Lapworth; Deema Basil Sadiq Jallad; Steve M. M. Sweet; Simon J. Morley

DDX3X, a helicase, can interact directly with mRNA and translation initiation factors, regulating the selective translation of mRNAs that contain a structured 5′ untranslated region. This activity modulates the expression of mRNAs controlling cell cycle progression and mRNAs regulating actin dynamics, contributing to cell adhesion and motility. Previously, we have shown that ribosomes and translation initiation factors localise to the leading edge of migrating fibroblasts in loci enriched with actively translating ribosomes, thereby promoting steady-state levels of ArpC2 and Rac1 proteins at the leading edge of cells during spreading. As DDX3X can regulate Rac1 levels, cell motility and metastasis, we have examined DDX3X protein interactions and localisation using many complementary approaches. We now show that DDX3X can physically interact and co-localise with poly(A)-binding protein 1 and caprin-1 at the leading edge of spreading cells. Furthermore, as depletion of DDX3X leads to decreased cell motility, this provides a functional link between DDX3X, caprin-1 and initiation factors at the leading edge of migrating cells to promote cell migration and spreading.


Cancer Research | 1986

Pharmacokinetics of monoclonal immunoglobulin G1 F(ab' ‘)2, and fab’ in mice

David G. Covell; Jacques Barbet; Oscar D. Holton; Christopher D.V. Black; Robert J. Parker; John N. Weinstein


Science | 1983

Monoclonal antibodies in the lymphatics: selective delivery to lymph node metastases of a solid tumor

John N. Weinstein; Michael A. Steller; Andrew M. Keenan; David G. Covell; Marc E. Key; Susan M. Sieber; Robert K. Oldham; Kou M. Hwang; Robert J. Parker


Science | 1982

Monoclonal anitbodies in the lymphatics: toward the diagnosis and therapy of tumor metastases.

John N. Weinstein; Robert J. Parker; Andrew M. Keenan; Steven K. Dower; Herbert C. Morse; Susan M. Sieber


Cancer Research | 1981

Lymphatic Absorption and Tissue Disposition of Liposome-entrapped [14C]Adriamycin following Intraperitoneal Administration to Rats

Robert J. Parker; Kathleen D. Hartman; Susan M. Sieber


Journal of Immunology | 1987

Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.

Oscar D. Holton; Christopher D.V. Black; Robert J. Parker; David G. Covell; J. Barbet; Susan M. Sieber; Mary Jane Talley; John N. Weinstein


AIDS Research and Human Retroviruses | 1990

Inhibition of HIV-1 in monocyte/macrophage cultures by 2',3'-dideoxycytidine-5'-triphosphate, free and in liposomes.

Janos Szebeni; Sharon M. Wahl; Gurupadappa V. Betageri; Larry M. Wahl; Suzanne Gartner; Mikulas Popovic; Robert J. Parker; Christopher D.V. Black; John N. Weinstein


Cancer Research | 1986

Optimization of Monoclonal Antibody Delivery via the Lymphatics:The Dose Dependence

Michael A. Steller; Robert J. Parker; David G. Covell; Oscar D. Holton; Andrew M. Keenan; Susan M. Sieber; John N. Weinstein

Collaboration


Dive into the Robert J. Parker's collaboration.

Top Co-Authors

Avatar

John N. Weinstein

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

David G. Covell

Science Applications International Corporation

View shared research outputs
Top Co-Authors

Avatar

Susan M. Sieber

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Andrew M. Keenan

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Oscar D. Holton

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Michael A. Steller

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alice Halliday

Liverpool School of Tropical Medicine

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge